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We thank the Amsterdam group for the interest and com-
ments on our article. We highly appreciate their contribu-
tion and investigation in the field of quantification of liver
function. However, in our survey we did not correlate the
impact of remnant liver volume on liver function in
patients with different underlying liver diseases. We pro-
vided an overview of current practices of liver surgery in
normal and cirrhotic livers. The critical size of 25% of
remnant liver volume was related to patients with normal
parenchyma [1].
Impaired function of the remaining liver is of major
concern for the hepatopancreatobiliary surgeon, particu-
larly in patients with an underlying liver disease. We
completely agree that in addition to the volume of remnant
liver the preoperative application of liver function tests
may have a relevant impact on the assessment of liver
function after resection in patients with underlying liver
disease. However, none of the metabolic tests available that
target hepatic physiology is currently widely accepted [2].
Metabolic tests are most often used in Asia, where most of
the patients undergoing liver surgery have hepatocellular
carcinoma related to hepatitis B or C cirrhosis. The most
commonly used test is intravenous injection of indocyanine
green (ICG). However, ICG results are not completely
reproducible because the rate of retention of indocyanine is
influenced by several factors, especially portal flow [3, 4].
According to our knowledge, there has been no con-
vincing evaluation of the impact of the ICG test in patients
after noncirrhotic liver resection. A recent publication by
the Amsterdam group on 99mTc-mebrofenin hepatobiliary
scintigraphy as an alternative metabolic liver function test
has produced promising results regarding the prediction of
postoperative liver failure [5]. Even so, reproducibility of
the accuracy of this examination needs to be confirmed by
other centers. In addition, its use requires a Department of
Nuclear Medicine to dispose of the radioisotope, and such
departments are not available everywhere in the world.
Certainly, further investigations are required to assess
the mechanism and the degree of liver disease that nega-
tively affect postoperative outcome. Functional liver tests
may play an increasing role in the future regarding pre-
operative risk assessment in patients undergoing liver
surgery.
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